As part of the All of Us research program, 10,000 volunteers' health indicators will be tracked by Fitbits, as the device straddles the line between consumer product and healthcare technology.
An appropriations subcommittee rejected a proposed multibillion-dollar cut to HHS funding over concerns that it could stymie medical innovation.
The Trump administration's 2018 budget proposed to merge the Agency for Healthcare Research and Quality with the National Institutes of Health. Experts say the move could benefit AHRQ if the consolidation is done right.
Dr. Norman E. Sharpless, director of UNC Lineberger Comprehensive Cancer Center, has been nominated to lead the National Cancer Institute, the largest division of the National Institutes of Health.
Congressional leaders and healthcare experts decried President Donald Trump's plan to slash the National Institutes of Health's budget Wednesday, saying it would prevent the organization from recruiting and retaining young scientists.
The 21st Century Cures Act signed by President Obama Tuesday has been ballyhooed as a major boost for NIH and cancer and brain research. But a closer look at the numbers reveals how little it offers—at a potentially high price.
For Steven Juliano, it's not how you kill disease-carrying mosquitoes. It's when. “I don't do mosquito control,” said the distinguished professor of ecology at Illinois State University. “I provide the information on where they're vulnerable.”
A company called Intelligent Retinal Imaging Systems, or IRIS, has developed a cloud-based platform and image-enhancement technology that connects primary-care physicians with optometrists and ophthalmologists who can read eye exam images taken during a normal doctor visit.
Northwestern University in Evanston, Ill., will lead a project with eight other universities to integrate patient-reported outcomes into electronic health records as part of a grant from the National Institutes of Health.
Data Points for the week of Sept. 26, 2016, covered the following topics: Clinical trials and the number of trials underway, penalties for not reporting results, and the percentage of cancer patients who participate in clinical trials.
Both Democrat Hillary Clinton and Republican Donald Trump have reportedly tapped policy experts with some healthcare experience for their transition teams.
After more than a decade of asking why factors such as race, ethnicity, income, gender and sexual orientation often correlate with worse health and healthcare quality for so many Americans, perhaps the biggest question is what can healthcare providers do about it.